Trial Profile
Clinical Trials Insight: 700041213
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Feb 2009
Price :
$35
*
At a glance
- Drugs Lexgenleucel T (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- Sponsors VIRxSYS Corporation
- 05 Feb 2009 New trial record.